Jeil Pharma Holdings Inc (KRX:002620)
South Korea · Delayed Price · Currency is KRW 7,000.00
+130.00 (1.89%)
Nov 13, 2026, 3:30 PM KST
Jeil Pharma Holdings Market Cap
Jeil Pharma Holdings has a market cap or net worth of 107.46 billion as of November 12, 2026. It is the 26,518th most valuable company in the world and the 1,176th biggest in South Korea. Its market cap has decreased by 10.83% in one year.
Market Cap
107.46B
Enterprise Value
360.88B
Revenue
630.89B
Global Rank
Country Rank
#1,176 South Korea
PE Ratio
12.75
ChartMarket Cap Chart
Since August 30, 1995, Jeil Pharma Holdings's market cap has increased from 26.30B to 107.46B, an increase of 308.65%. That is a compound annual growth rate of 4.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 107.46B | -12.94% |
| Dec 30, 2025 | 123.42B | 2.81% |
| Dec 30, 2024 | 120.05B | -33.56% |
| Dec 28, 2023 | 180.68B | -23.57% |
| Dec 29, 2022 | 236.41B | -3.75% |
| Dec 30, 2021 | 245.62B | -24.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hana Pharm | 146.80B |
| Dongwha Pharm.Co.,Ltd | 146.07B |
| Ilsung Is | 145.65B |
| AptaBio Therapeutics | 133.02B |
| Jeil Pharmaceutical Co.,Ltd | 128.96B |
| Ilyang Pharmaceutical Co.,Ltd | 122.79B |
| Kyongbo Pharmaceutical | 119.53B |
| SAMSUNG PHARM. Co., LTD. | 113.79B |